← Back to Search

Snack beverage for Cystic Fibrosis (SNACK_CF Trial)

N/A
Waitlist Available
Led By Rémi Rabasa-Lhoret, MD, PhD
Research Sponsored by Institut de Recherches Cliniques de Montreal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up overall study period (4 hours)
Awards & highlights

SNACK_CF Trial Summary

This trial tests if a pre-meal snack and postprandial exercise can help reduce PPG excursions in adult CF patients.

Eligible Conditions
  • Cystic Fibrosis

SNACK_CF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~overall study period (4 hours)
This trial's timeline: 3 weeks for screening, Varies for treatment, and overall study period (4 hours) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total area under the curve for plasma glucose
Secondary outcome measures
Area under the curve for insulin
Area under the curve for plasma glucose
Mean insulin
+7 more

SNACK_CF Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: [Snack effect + Sedentary]Experimental Treatment1 Intervention
2) Consumption of 200ml of soy beverage + 90g of carbohydrate (CHO) breakfast for men and 80g for women; Sedentary activities throughout the study
Group II: [Snack + Exercise]Experimental Treatment2 Interventions
4) Consumption of 200ml of soy beverage + breakfast of 90g of carbohydrate (CHO) breakfast for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5).
Group III: [Placebo + Exercise]Experimental Treatment1 Intervention
3) Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5);
Group IV: [Placebo + Sedentary]Active Control1 Intervention
1) Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women; Sedentary activities throughout the study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Snack beverage
2019
N/A
~20
Exercise
2016
Completed Phase 1
~760

Find a Location

Who is running the clinical trial?

Institut de Recherches Cliniques de MontrealLead Sponsor
70 Previous Clinical Trials
10,354 Total Patients Enrolled
6 Trials studying Cystic Fibrosis
378 Patients Enrolled for Cystic Fibrosis
Rémi Rabasa-Lhoret, MD, PhDPrincipal InvestigatorIRCM
12 Previous Clinical Trials
263 Total Patients Enrolled
2 Trials studying Cystic Fibrosis
37 Patients Enrolled for Cystic Fibrosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open for this clinical trial?

"As per the information on clinicaltrials.gov, this experiment is no longer recruiting participants; the initial posting was made April 1st 2019 and it was last updated July 26th 2022. Despite not currently searching for candidates in this trial, there are 417 other trials that presently have open enrollment periods."

Answered by AI
~2 spots leftby Apr 2025